United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$87Mraised across 4 rounds since 2009, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding record
No investor was named in the report.
From a historical funding record
No investor was named in the report.
From a historical funding recordSEC filing: $2.4M sold, first sale Aug 2009
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Deerfield
Iroquois Capital
Heights Capital ManagementDAFNA Capital Management, LLC
Lincoln Park Capital FundMissing a round, or an investor who was in one? Tell us.
Raptor Pharmaceuticals's investors include Deerfield, Iroquois Capital, Heights Capital Management, DAFNA Capital Management, LLC and Lincoln Park Capital Fund.
Raptor Pharmaceuticals has raised $87M across 4 rounds since 2009.
Raptor Pharmaceuticals's most recent round was a Debt of $10M in Jul 2014.
Raptor Pharmaceuticals's largest round on record is $60M (Undisclosed round), in Jul 2014.
Raptor Pharmaceuticals's first round on record, in Aug 2010, was backed by Deerfield, Iroquois Capital and Heights Capital Management and 2 others.
Raptor Pharmaceuticals's latest named round is a Debt, in Jul 2014.
Raptor Pharmaceuticals is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
